Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs

European Journal of Clinical Pharmacology

Volumn 67, Issue 9, 2011, Pages 933-940

  Uijtendaal, Esther V ^a   Rijkom, Jeannette E F Zwart Van ^a,b   Solinge, Wouter W Van ^a,b   Egberts, Toine C G ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Clinical decision support; Clinical risk management; Drug drug interactions; Hyperkalaemia; Monitoring; Potassium

Indexed keywords

ANGIOTENSIN ANTAGONIST; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; RENIN INHIBITOR;

ADULT; ARTICLE; CLINICAL DECISION MAKING; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG COMPETITION; DRUG MONITORING; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; HOME CARE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERKALEMIA; KIDNEY FAILURE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; BLOOD CHEMICAL ANALYSIS; COHORT STUDIES; DATABASES, FACTUAL; DRUG INTERACTIONS; DRUG MONITORING; HOSPITALIZATION; HUMANS; HYPERKALEMIA; NETHERLANDS; PHARMACEUTICAL PREPARATIONS; POTASSIUM; RISK FACTORS; RISK MANAGEMENT;

EID: 80054789751     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1028-1     Document Type: Article

References (27)

1. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM (2008) Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 168:1890-1896
2. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA (2003) Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 289:1652-1658 (Pubitemid 37430270)
3. Buurma H, De Smet PA, Egberts AC (2006) Clinical risk management in Dutch community pharmacies: The case of drugdrug interactions. Drug Saf 29:723-732 (Pubitemid 44175043)
4. Zwart-van Rijkom JE, Uijtendaal EV, ten Berg MJ, van Solinge WW, Egberts AC (2009) Frequency and nature of drug-drug interactions in a Dutch university hospital. Br J Clin Pharmacol 68:187-193
5. Perazella MA, Mahnensmith RL (1997) Hyperkalemia in the elderly: Drugs exacerbate impaired potassium homeostasis. J Gen Intern Med 12:646-656 (Pubitemid 27446620)
6. Pitt B, RALES study group (1996) Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am J Cardiol 78:902-907 (Pubitemid 126658651)
7. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351:543-551 (Pubitemid 39025171)
8. Cruz CS, Cruz AA, Marcilio de Souza CA (2003) Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone. Nephrol Dial Transplant 18:1814-1819 (Pubitemid 37098553)
9. Desai A (2008) Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: Balancing risk and benefit. Circulation 118:1609-1611
10. Henz S, Maeder MT, Huber S, Schmid M, Loher M, Fehr T (2008) Influence of drugs and comorbidity on serum potassium in 15 000 consecutive hospital admissions. Nephrol Dial Transplant 23:3939-3945
11. Johnson ES, Weinstein JR, Thorp ML, Platt RW, Petrik AF, Yang X, Anderson S, Smith DH (2010) Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril. Pharmacoepidemiol Drug Saf 19:266-272
12. van Roon EN, Flikweert S, le Comte M, Langendijk PN, Kwee-Zuiderwijk WJ, Smits P, Brouwers JR (2005) Clinical relevance of drug-drug interactions: A structured assessment procedure. Drug Saf 28:1131-1139 (Pubitemid 41776003)
13. Z-index (2008) Z-index. Available at: Http://www.z-index.nl/ Accessed January 2009
14. WHO Collaborating Center for Drug Statistics Methodology (2009) Anatomical Therapeutic Chemical (ATC) classification index. Available at: Http://www.whocc.no/ Accessed January 2009
15. ten Berg MJ, Huisman A, van den Bemt PM, Schobben AF, Egberts AC, van Solinge WW (2007) Linking laboratory and medication data: New opportunities for pharmacoepidemiological research. Clin Chem Lab Med 45:13-19 (Pubitemid 46155553)
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 130:461-470 (Pubitemid 29135798)
17. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, van Lente LF (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247-254 (Pubitemid 46768608)
18. Weinberg JM, Appel LJ, Bakris G, Gassman JJ, Greene T, Kendrick CA, Wang X, Lash J, Lewis JA, Pogue V, Thornley-Brown D, Philips RA (2009) Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy. Arch Intern Med 169:1587-1594
19. Einhorn LM, Zhan M, Hsu VD, Walker LD, Moen MF, Seliger SL, Weir MR, Fink JC (2009) The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 169:1156-1162
20. Bakris GL, Siomos M, Richardson D, Janssen I, Bolton WK, Hebert L, Agarwal R, Catanzaro D (2000) ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure. VAL-K Study Group. Kidney Int 58:2084-2092
21. Stevens MS, Dunlay RW (2000) Hyperkalemia in hospitalized patients. Int Urol Nephrol 32:177-180 (Pubitemid 32140484)
22. Ponce SP, Jennings AE, Madias NE, Harrington JT (1985) Druginduced hyperkalemia. Medicine 64:357-370
23. Vereijken TL, Bellersen L, Groenewoud JM, Knubben L, Baltussen L, Kramers C (2007) Risk calculation for hyperkalaemia in heart failure patients. Neth J Med 65:208-211 (Pubitemid 47007914)
24. van der Sijs H, Mulder A, van Gelder T, Aarts J, Berg M, Vulto A (2009) Drug safety alert generation and overriding in a large Dutch university medical centre. Pharmacoepidemiol Drug Saf 18:941-947
25. Velthove KJ, Leufkens HG, Souverein PC, Schweizer RC, van Solinge WW (2010) Testing bias in clinical databases: Methodological considerations. Emerg Themes Epidemiol 7:2-9
26. van der Sijs H, Aarts J, Vulto A, Berg M (2006) Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 13:138-147 (Pubitemid 43332904)
27. Weingart SN, Toth M, Sands DZ, Aronson MD, Davis RB, Phillips RS (2003) Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med 163:2625-2631 (Pubitemid 37464421)